Key result
High-fat diet plus L-NAME drives HFpEF via fibroblast-derived ANGPTL4 impairing cardiac endothelial cells.
Why the study?
Effective therapies for HFpEF are limited by a poor understanding of its pathophysiological basis, motivating single-cell characterization of its cellular heterogeneity and potential mechanisms.
Does HFpEF induced by a high-fat diet and L-NAME alter the single-cell transcriptomic landscape of cardiac non-cardiomyocytes and impair angiogenesis in mice?
Does HFpEF induced by a high-fat diet and L-NAME alter the single-cell transcriptomic landscape of cardiac non-cardiomyocytes and impair angiogenesis in mice?
Single-cell profiling of HFpEF mouse hearts identifies fibroblast-derived ANGPTL4 as a potential mediator of microvascular rarefaction and a candidate druggable target for HFpEF.
Answers are grounded in this paper and cite their sources.
May implicate ANGPTL4 in HFpEF microvascular rarefaction; hypothesis-generating for targeting, pending human validation.
INTRODUCTION: Despite the high morbidity and mortality, the effective therapies for heart failure with preserved fraction (HFpEF) are limited as the poor understand of its pathophysiological basis. OBJECTIVE: This study was aimed to characterize the cellular heterogeneity and potential mechanisms of HFpEF at single-cell resolution. METHODS: An HFpEF mouse model was induced by a high-fat diet with N-nitro-L-arginine methyl ester. Cells from the hearts were subjected to single-cell sequencing. The key protein expression was measured with Immunohistochemistry and immunofluorescence staining. RESULTS: In HFpEF hearts, myocardial fibroblasts exhibited higher levels of fibrosis. Furthermore, an increased number of fibroblasts differentiated into high-metabolism and high-fibrosis phenotypes. The expression levels of genes encoding certain pro-angiogenic secreted proteins were decreased in the HFpEF group, as confirmed by bulk RNA sequencing. Additionally, the proportion of the endothelial cell (EC) lineages in the HFpEF group was significantly downregulated, with low angiogenesis and high apoptosis phenotypes observed in these EC lineages. Interestingly, the fibroblasts in the HFpEF heart might cross-link with the EC lineages via over-secretion of ANGPTL4, thus displaying an anti-angiogenic function. Immunohistochemistry and immunofluorescence staining then revealed the downregulation of vascular density and upregulation of ANGPTL4 expression in HFpEF hearts. Finally, we predicted ANGPTL4as a potential druggable target using DrugnomeAI. CONCLUSION: In conclusion, this study comprehensively characterized the angiogenesis impairment in HFpEF hearts at single-cell resolution and proposed that ANGPTL4 secretion by fibroblasts may be a potential mechanism underlying this angiogenic abnormality.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied Heart failure with preserved ejection fraction (HFpEF) (n=16). High-fat diet and N-nitro-L-arginine methyl ester (L-NAME) vs. Normal diet and water was evaluated on Single-cell transcriptomic profiling of non-cardiomyocytes, intercellular communication, and ANGPTL4 expression. High-fat diet plus L-NAME induced HFpEF in mice, increasing fibrotic fibroblasts and reducing endothelial cells via fibroblast over-secretion of anti-angiogenic ANGPTL4.
Synapse has enriched 10 related papers. Consider them for comparative context: